This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Cançado RD, Araújo A da S, Sandes AF, Arrais C, Lobo CL de C, Figueiredo MS, et al. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematol Transfus Cell Ther. September 2021;43(3):341–8.CançadoRDAraújoA da SSandesAFArraisCLoboCL de CFigueiredoMSet alConsensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuriaHematol Transfus Cell Ther. September2021433341810.1016/j.htct.2020.06.006844625532713742Search in Google Scholar
Risitano AM, Rotoli B. Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents. Biologics. June 2008;2(2):205–22.RisitanoAMRotoliBParoxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agentsBiologics. June2008222052210.2147/BTT.S1420272135719707355Search in Google Scholar
Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. May 2014;99(5):922–9.SchrezenmeierHMuusPSociéGSzerJUrbano-IspizuaAMaciejewskiJPet alBaseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria RegistryHaematologica. May2014995922910.3324/haematol.2013.093161400811424488565Search in Google Scholar
Parker C, Omine M, Richards S, Nishimura J-I, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 1 December 2005;106(12):3699–709.ParkerCOmineMRichardsSNishimuraJ-IBesslerMWareRet alDiagnosis and management of paroxysmal nocturnal hemoglobinuriaBlood. 1 December200510612369970910.1182/blood-2005-04-1717189510616051736Search in Google Scholar
Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, González A, et al. [Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria]. Med Clin (Barc). 18 March 2016;146(6):278.e1-7.VillegasAArrizabalagaBBonanadSColadoEGayaAGonzálezAet al[Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria]Med Clin (Barc). 18 March20161466278e1-7.10.1016/j.medcle.2016.05.008Search in Google Scholar
Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 30 October 2014;124(18):2804–11.BrodskyRAParoxysmal nocturnal hemoglobinuriaBlood. 30 October20141241828041110.1182/blood-2014-02-522128421531125237200Search in Google Scholar
Notaro R, Sica M. C3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implications. Semin Hematol. July 2018;55(3):130–5.NotaroRSicaMC3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implicationsSemin Hematol. July2018553130510.1053/j.seminhematol.2018.05.01430032749Search in Google Scholar
Parker CJ. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program. 2 December 2016;2016(1):208–16.ParkerCJUpdate on the diagnosis and management of paroxysmal nocturnal hemoglobinuriaHematology Am Soc Hematol Educ Program. 2 December2016201612081610.1182/asheducation-2016.1.208614251727913482Search in Google Scholar
Richards SJ, Painter D, Dickinson AJ, Griffin M, Munir T, Arnold L, et al. The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population based haematological malignancy research network 2004 2018. Eur J Haematol. August 2021;107(2):211–8.RichardsSJPainterDDickinsonAJGriffinMMunirTArnoldLet alThe incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population based haematological malignancy research network 2004 2018Eur J Haematol.August20211072211810.1111/ejh.1364034060690Search in Google Scholar
Hall SE, Rosse WF. The Use of Monoclonal Antibodies and Flow Cytometry in the Diagnosis of Paroxysmal Nocturnal Hemoglobinuria. Blood. 15 June 1996;87(12):5332–40.HallSERosseWFThe Use of Monoclonal Antibodies and Flow Cytometry in the Diagnosis of Paroxysmal Nocturnal HemoglobinuriaBlood. 15 June1996871253324010.1182/blood.V87.12.5332.bloodjournal87125332Search in Google Scholar
Richards SJ, Barnett D. The role of flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria in the clinical laboratory. Clin Lab Med.September 2007;27(3):577–90.RichardsSJBarnettDThe role of flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria in the clinical laboratoryClin Lab Med.September20072735779010.1016/j.cll.2007.05.01217658408Search in Google Scholar